Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024)
Historic Current Leases for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q4 2024 value amounting to $268000.0.
- Whitehawk Therapeutics' Current Leases fell 3824.88% to $268000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $268000.0, marking a year-over-year decrease of 3824.88%. This contributed to the annual value of $268000.0 for FY2024, which is 3824.88% down from last year.
- Per Whitehawk Therapeutics' latest filing, its Current Leases stood at $268000.0 for Q4 2024, which was down 3824.88% from $322000.0 recorded in Q3 2024.
- In the past 5 years, Whitehawk Therapeutics' Current Leases ranged from a high of $434000.0 in Q4 2023 and a low of $9955.0 during Q2 2021
- Moreover, its 5-year median value for Current Leases was $322000.0 (2024), whereas its average is $257931.6.
- Per our database at Business Quant, Whitehawk Therapeutics' Current Leases plummeted by 9103.58% in 2021 and then soared by 315464.59% in 2022.
- Whitehawk Therapeutics' Current Leases (Quarter) stood at $94787.0 in 2020, then skyrocketed by 38.2% to $131000.0 in 2021, then soared by 200.76% to $394000.0 in 2022, then rose by 10.15% to $434000.0 in 2023, then plummeted by 38.25% to $268000.0 in 2024.
- Its Current Leases stands at $268000.0 for Q4 2024, versus $322000.0 for Q3 2024 and $374000.0 for Q2 2024.